1. Sasahira, Tomonori, Nishiguchi, Yukiko, Kurihara-Shimomura, Miyako, Kuniyasu, Hiroki, Kirita, Tadaaki. 2018. NIPA-like domain containing 1 is a novel tumor-promoting factor in oral squamous cell carcinoma. In Journal of cancer research and clinical oncology, 144, 875-882. doi:10.1007/s00432-018-2612-x. https://pubmed.ncbi.nlm.nih.gov/29464350/
2. Manialawy, Yousef, Khan, Saifur R, Bhattacharjee, Alpana, Wheeler, Michael B. 2020. The magnesium transporter NIPAL1 is a pancreatic islet-expressed protein that conditionally impacts insulin secretion. In The Journal of biological chemistry, 295, 9879-9892. doi:10.1074/jbc.RA120.013277. https://pubmed.ncbi.nlm.nih.gov/32439805/
3. Parker, Heidi G, Harris, Alexander C, Plassais, Jocelyn, Knapp, Deborah W, Ostrander, Elaine A. 2024. Genome-wide analyses reveals an association between invasive urothelial carcinoma in the Shetland sheepdog and NIPAL1. In NPJ precision oncology, 8, 112. doi:10.1038/s41698-024-00591-0. https://pubmed.ncbi.nlm.nih.gov/38778091/
4. Zhang, Yanfei, Grant, Ryan A, Shivakumar, Manu K, Williams, Marc S, Lee, Ming Ta Michael. . Genome-wide Association Analysis Across 16,956 Patients Identifies a Novel Genetic Association Between BMP6, NIPAL1, CNGA1 and Spondylosis. In Spine, 46, E625-E631. doi:10.1097/BRS.0000000000003880. https://pubmed.ncbi.nlm.nih.gov/33332786/
5. Nakayama, Akiyoshi, Nakaoka, Hirofumi, Yamamoto, Ken, Merriman, Tony R, Matsuo, Hirotaka. 2016. GWAS of clinically defined gout and subtypes identifies multiple susceptibility loci that include urate transporter genes. In Annals of the rheumatic diseases, 76, 869-877. doi:10.1136/annrheumdis-2016-209632. https://pubmed.ncbi.nlm.nih.gov/27899376/
6. Zhu, Weifeng, Deng, Yan, Zhou, Xiaodong. 2018. Multiple Membrane Transporters and Some Immune Regulatory Genes are Major Genetic Factors to Gout. In The open rheumatology journal, 12, 94-113. doi:10.2174/1874312901812010094. https://pubmed.ncbi.nlm.nih.gov/30123371/
7. Zhu, Youlong, Qi, Zongze, Zu, Shaoqi, Li, Ruixue, Zhu, Hong. 2025. NIPAL1 as a prognostic biomarker associated with pancreatic adenocarcinoma progression and immune infiltration. In BMC cancer, 25, 165. doi:10.1186/s12885-025-13567-5. https://pubmed.ncbi.nlm.nih.gov/39875873/